Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

US Patent 10905772 · Granted Feb 2, 2021

Estimated economic value: $295,872,000

Assignee

Inventors

View full patent text on Google Patents →